Association of Time Between Left Ventricular and Aortic Systolic Pressure Peaks With Severity of Aortic Stenosis and Calcification of Aortic Valve.


Journal

JAMA cardiology
ISSN: 2380-6591
Titre abrégé: JAMA Cardiol
Pays: United States
ID NLM: 101676033

Informations de publication

Date de publication:
01 06 2019
Historique:
pubmed: 2 5 2019
medline: 18 6 2020
entrez: 2 5 2019
Statut: ppublish

Résumé

Diagnosis of low-gradient severe aortic stenosis (AS) is challenging. We hypothesized that the time between left ventricular (LV) and aortic systolic pressure peaks (TLV-Ao) is associated with aortic stenosis (AS) severity and may have additive value in diagnosing severe AS, especially in patients with low-gradient AS. To investigate the diagnostic utility of measuring catheter-based TLV-Ao in patients with severe AS. We studied 123 patients with severe AS at the Cleveland Clinic Foundation, a tertiary referral center, who underwent transcatheter aortic valve replacement (TAVR) via femoral access and had pre-TAVR cardiac computed tomography assessment and hemodynamic measurements recorded during a TAVR procedure. All patients received hemodynamic evaluation, echocardiographic assessment, and quantification of aortic valve calcification (AVC) by multidetector computed tomography. Hemodynamic data were collected via left heart catheterization done just before TAVR, and TLV-Ao was calculated offline. Data were analyzed between October 5, 2015, and July 20, 2016. The association between TLV-Ao and AVC or other conventional imaging parameters was analyzed. Of the included patients, the mean (SD) age was 81 (9) years, and 65 (54%) were men (54%). Among 123 patients, 48 patients (39%) had low-gradient AS (<40 mm Hg) and mean (SD) TLV-Ao was 69 (39) milliseconds. In multivariable logistic regression analyses, higher TLV-Ao (odds ratio [OR], 1.02; 95% CI, 1.01-1.04; P = .002) and higher peak aortic valve (AV) velocity (OR, 1.01; 95% CI, 1.00-1.02; P = .008) were independently associated with severe AVC (AVC >1000 AU). Adding TLV-Ao to the peak AV velocity and AV area showed significant incremental value to be associated with AVC, with a net reclassification improvement of 0.61 (95% CI, 0.23-0.99; P = .002) and integrated discriminatory improvement of 0.09 (95% CI, 0.03-0.16; P = .003). In a subgroup of patients with low-grade AS, higher TLV-Ao was the only parameter associated with severe AVC (OR, 1.02; 95% CI, 1.001-1.04; P = .03). Prolonged TLV-Ao was associated with severe AVC. This catheter-based hemodynamic index may be an additional surrogate to differentiate low-gradient true severe AS. Larger, prospective studies investigating the role of TLV-Ao as a marker of clinical outcomes in patients undergoing TAVR are required.

Identifiants

pubmed: 31042265
pii: 2731733
doi: 10.1001/jamacardio.2019.1180
pmc: PMC6495352
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

549-555

Commentaires et corrections

Type : CommentIn
Type : ErratumIn

Références

Stat Med. 2008 Jan 30;27(2):157-72; discussion 207-12
pubmed: 17569110
J Am Heart Assoc. 2016 Oct 22;5(10):
pubmed: 27792660
Eur J Epidemiol. 2011 Apr;26(4):261-4
pubmed: 21431839
Circ Cardiovasc Imaging. 2018 Mar;11(3):e007146
pubmed: 29555836
J Am Soc Echocardiogr. 2017 Apr;30(4):372-392
pubmed: 28385280
Circulation. 1973 Mar;47(3):527-33
pubmed: 4692211
J Cardiovasc Comput Tomogr. 2017 Jul - Aug;11(4):302-308
pubmed: 28457950
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14
pubmed: 25559473
Catheter Cardiovasc Interv. 2016 Feb 15;87(3):488-97
pubmed: 26033475
JACC Cardiovasc Imaging. 2011 Nov;4(11):1161-70
pubmed: 22093266
Circulation. 2014 Jun 10;129(23):e521-643
pubmed: 24589853
AJR Am J Roentgenol. 2008 Mar;190(3):748-54
pubmed: 18287448
J Cardiovasc Comput Tomogr. 2017 Mar - Apr;11(2):99-104
pubmed: 28209366
J Am Soc Echocardiogr. 2017 Oct;30(10):947-955
pubmed: 28781116
J Am Coll Cardiol. 2014 Sep 23;64(12):1202-13
pubmed: 25236511
Circulation. 2009 Jan 6;119(1):9-12
pubmed: 19103984
Clin Cardiol. 2014 Jan;37(1):26-31
pubmed: 24122890
J Am Coll Cardiol. 2013 Dec 17;62(24):2329-38
pubmed: 24076528
Stat Med. 2011 Jan 15;30(1):11-21
pubmed: 21204120
J Am Coll Cardiol. 2009 Sep 8;54(11):1003-11
pubmed: 19729117

Auteurs

Kimi Sato (K)

Heart and Vascular Institute, Cleveland Clinic Foundation, Cleveland, Ohio.

Arnav Kumar (A)

Heart and Vascular Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
Andreas Gruentzig Cardiovascular Center, Emory University School of Medicine, Atlanta, Georgia.

Yash Jobanputra (Y)

Heart and Vascular Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
University of Miami Miller School of Medicine, Palm Beach Regional Campus, Palm Beach, Florida.

Jorge Betancor (J)

Heart and Vascular Institute, Cleveland Clinic Foundation, Cleveland, Ohio.

Mohamed Halane (M)

Heart and Vascular Institute, Cleveland Clinic Foundation, Cleveland, Ohio.

Robin George (R)

Heart and Vascular Institute, Cleveland Clinic Foundation, Cleveland, Ohio.

Vivek Menon (V)

Heart and Vascular Institute, Cleveland Clinic Foundation, Cleveland, Ohio.

Amar Krishnaswamy (A)

Heart and Vascular Institute, Cleveland Clinic Foundation, Cleveland, Ohio.

E Murat Tuzcu (EM)

Heart and Vascular Institute, Cleveland Clinic Foundation, Cleveland, Ohio.

Serge Harb (S)

Heart and Vascular Institute, Cleveland Clinic Foundation, Cleveland, Ohio.

Wael A Jaber (WA)

Heart and Vascular Institute, Cleveland Clinic Foundation, Cleveland, Ohio.

Stephanie Mick (S)

Heart and Vascular Institute, Cleveland Clinic Foundation, Cleveland, Ohio.

Lars G Svensson (LG)

Heart and Vascular Institute, Cleveland Clinic Foundation, Cleveland, Ohio.

Samir R Kapadia (SR)

Heart and Vascular Institute, Cleveland Clinic Foundation, Cleveland, Ohio.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH